Grants and Contributions

The objective is to invest in targeted COVID priority research areas from the Fall 2020 Project Grant competition such as vaccine hesitancy, pregnant women and children, racialized populations, Indigenous, confidence in science and SARS-CoV-2 variants.

Canada’s Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, provincial health authorities, health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of research into care. Its vision is that by 2025, Canada will have demonstrably improved health outcomes and enhanced the health care experience for patients through the integration of evidence at all levels of the health care system.

As outlined in the SPOR Patient Engagement Framework, patient-oriented research refers to a continuum of research that engages patients as partners, focusses on patient-identified priorities and improves patient outcomes. This research, conducted by multidisciplinary teams in partnership with relevant stakeholders, aims to apply the knowledge generated to improve healthcare systems and practices.
As a partner in SPOR, CIHR will provide bridge funding for fundable applications that are below the competition funding cut-off and aligned with the SPOR vision and the SPOR Patient Engagement Framework. Categories are described in the Funds Available section.

• The Indigenous Healthy Life Trajectories Initiative, under the leadership of the CIHR Institute of Indigenous Peoples’ Health (IIPH) and the CIHR Institute of Human Development, Child and Youth Health (IHDCYH) will provide bridge funding for applications that are both within the mandate of IIPH and that are relevant to healthy pregnancy and/or early child development in Indigenous contexts. This includes research with a focus on the developmental origins of health and disease (DOHaD)

The Project Grant program is expected to:

• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

• This Prize was established to recognize the excellence of cancer research being conducted in Canada. This prize will be given annually to the highest ranking Early Career Investigators in the Project Scheme competitions that fall within the Institute of Cancer Research (ICR) mandate:
o ICR has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.

• Incorporating sex and gender into health research makes for better science that is more rigorous and more applicable to the needs of everybody. The Institute of Gender and Health (IGH) will provide bridge funding for applications that are relevant to its mandate:
o CIHR-IGH mandate is to foster research excellence regarding the influence of sex and gender on health and to apply these findings to identify and address pressing health challenges facing men, women, girls, boys and gender-diverse people.
• These one (1) year operating grants afford Principal Investigators an opportunity to resubmit their research proposal without the loss of momentum, staff, or trainees.

The overall goal of this pan-Canadian initiative is to position Canada for the rapid translation of epigenetic discoveries into diagnostic procedures and the eventual development of new therapeutics that can improve human health. By supporting and applying epigenetics research on a national scale, CEEHRC is harnessing its great potential for major breakthroughs in understanding the origins of health and also the etiology, treatment and prevention of many of the chronic diseases currently affecting the Canadian population. Specific CEEHRC objectives include:
•Establishment of a national epigenetics platform that will serve as an essential resource for the generation of human reference epigenomes and that will coordinate national efforts in epigenomic research.
•Translation of epigenetic research discoveries into clinical and medical practice by supporting large-scale epigenetics research. This includes the development of novel molecular tools for diagnostic and therapeutic applications to a wide range of complex disorders.
•Positioning Canadian researchers, clinicians and policy-makers at the forefront of epigenetics science and its translation into health-care deliverables by playing a leadership role in IHEC and other international epigenetics initiatives.

• Incorporating sex and gender into health research makes for better science that is more rigorous and more applicable to the needs of everybody. The Institute of Gender and Health (IGH) will provide bridge funding for applications that are relevant to its mandate:
o CIHR-IGH mandate is to foster research excellence regarding the influence of sex and gender on health and to apply these findings to identify and address pressing health challenges facing men, women, girls, boys and gender-diverse people.
• These one (1) year operating grants afford Principal Investigators an opportunity to resubmit their research proposal without the loss of momentum, staff, or trainees.

The objective is to invest in targeted COVID priority research areas from the Fall 2020 Project Grant competition such as vaccine hesitancy, pregnant women and children, racialized populations, Indigenous, confidence in science and SARS-CoV-2 variants.

The Project Grant program is expected to:

• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.